Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors
Carella, A. M., Corradini, P., Mussetti, A., Ricardi, U., Vitolo, U., Viviani, S.Language:
english
Journal:
Annals of Hematology
DOI:
10.1007/s00277-018-3366-x
Date:
May, 2018
File:
PDF, 528 KB
english, 2018